会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Closed loop control of cardiac stimulator utilizing rate of change of
impedance
    • 利用阻抗变化率对心脏刺激器进行闭环控制
    • US4733667A
    • 1988-03-29
    • US895241
    • 1986-08-11
    • Arthur L. OliveBrian D. PedersonRodney W. Salo
    • Arthur L. OliveBrian D. PedersonRodney W. Salo
    • A61N1/365A61N1/36
    • A61N1/36521
    • A cardiac pacer of the type having an implantable pulse generator and electrical leads deployed in the right ventricular chamber of the heart. The lead has a stimulating electrode as well as a plurality of sensing electrodes coupled to the pulse generator. Certain control circuitry associated with the implantable pacer provides for measurement of the impedance variations occasioned by the pumping action of the heart and a differentiating circuit operatively coupled to the impedance sensing circuit for developing a control signal corresponding to the rate of change of the impedance with respect to time. This control signal may be coupled to the timing circuit of the implantable pulse generator, allowing the pacing rate to be altered in accordance with the level of physiologic activity of the person in whom the pacer is implanted.
    • 该类型的心脏起搏器具有部署在心脏右心室的植入式脉冲发生器和电引线。 引线具有刺激电极以及耦合到脉冲发生器的多个感测电极。 与可植入起搏器相关联的某些控制电路提供用于测量由心脏的泵送作用引起的阻抗变化,以及可操作地耦合到阻抗感测电路的差分电路,用于开发对应于阻抗变化率的控制信号 到时间 该控制信号可以耦合到可植入脉冲发生器的定时电路,允许起搏速率根据其中植入人的人的生理活动水平而改变。
    • 6. 发明授权
    • Biomedical method and apparatus for controlling the administration of
therapy to a patient in response to changes in physiologic demand
    • 生物医学方法和装置,用于响应于生理需求的变化来控制对患者的治疗施用
    • US4686987A
    • 1987-08-18
    • US362903
    • 1982-03-29
    • Rodney W. SaloBrian D. Pederson
    • Rodney W. SaloBrian D. Pederson
    • A61N1/365A61N1/36
    • A61N1/36521
    • A biomedical apparatus capable of sensing changes in the heart's ventricular volume or stroke volume and then changing the operating performance of the device in a fashion as a function of stroke volume. A relatively low frequency signal (under 5 KHz) is applied between spaced electrodes disposed in the heart and the beating action of the heart serves to modulate this signal due to changes in impedance being sensed between these or other electrodes within the heart. The modulated carrier signal is then processed to remove R-wave and other electrical artifacts and then demodulated to remove the carrier frequency component leaving the envelope which is proportional to instantaneous ventricular volume. This envelope signal then contains stroke volume and ventricular volume information which can be used by the biomedical apparatus to vary its operating parameters. For example, a current proportional to changes in stroke volume may be injected into the timing circuit of a demand-type cardiac pacer pulse generator whereby the interpulse interval of the pulse generator is varied as a function of stroke volume.
    • 一种生物医学装置,其能够感测心脏体积或冲程体积的变化,然后以作为行程体积的函数的方式改变装置的操作性能。 相对较低的频率信号(低于5KHz)被施加在设置在心脏中的间隔电极之间,并且心脏的跳动作用是由于在心脏内的这些或其它电极之间感测的阻抗的变化来调制该信号。 然后处理调制载波信号以去除R波和其他电气伪影,然后解调以去除离开与瞬时心室容积成比例的包络的载波频率分量。 然后,该包络信号包含可由生物医学装置用于改变其操作参数的搏动体积和心室容积信息。 例如,与笔画体积变化成比例的电流可以被注入到需求型心脏起搏器脉冲发生器的定时电路中,由此脉冲发生器的脉冲间隔作为行程体积的函数而变化。
    • 7. 发明授权
    • Biomedical method and apparatus for controlling the administration of
therapy to a patient in response to changes in physiological demand
    • 生物医学方法和装置,用于响应于生理需求的变化来控制对患者的治疗施用
    • US5190035A
    • 1993-03-02
    • US853059
    • 1986-04-17
    • Rodney W. SaloBrian D. Pederson
    • Rodney W. SaloBrian D. Pederson
    • A61N1/365
    • A61N1/36521
    • A biomedical apparatus capable of sensing changes in the heart's ventricular volume or stroke volume and then changing the operating performance of the device in a fashion as a function of stroke volume. A relatively low frequency signal (under 5 KHz) is applied between spaced electrodes disposed in the heart and the beating action of the heart serves to modulate this signal due to changes in impedance being sensed between these or other electrodes within the heart. The modulated carrier signal is then processed to remove R-wave and other electrical artifacts and then demodulated to remove the carrier frequency component leaving the envelope which is proportional to instantaneous ventricular volume. This envelope signal then contains stroke volume and ventricular volume information which can be used by the biomedical apparatus to vary its operating parameters. For example, a current proportional to changes in stroke volume may be injected into the timing circuit of a demand-type cardiac pacer pulse generator whereby the interpulse interval of the pulse generator is varied as a function of stroke volume.
    • 一种生物医学装置,其能够感测心脏体积或冲程体积的变化,然后以作为行程体积的函数的方式改变装置的操作性能。 相对较低的频率信号(低于5KHz)被施加在设置在心脏中的间隔电极之间,并且心脏的跳动作用是由于在心脏内的这些或其它电极之间感测的阻抗的变化来调制该信号。 然后处理调制载波信号以去除R波和其他电气伪影,然后解调以去除离开与瞬时心室容积成比例的包络的载波频率分量。 然后,该包络信号包含可由生物医学装置用于改变其操作参数的搏动体积和心室容积信息。 例如,与笔画体积变化成比例的电流可以被注入到需求型心脏起搏器脉冲发生器的定时电路中,由此脉冲发生器的脉冲间隔作为行程体积的函数而变化。
    • 8. 发明授权
    • Dimension sensitive angioplasty catheter
    • 尺寸敏感血管成形术导管
    • US4587975A
    • 1986-05-13
    • US626719
    • 1984-07-02
    • Rodney W. SaloBrian D. Pederson
    • Rodney W. SaloBrian D. Pederson
    • A61B5/053A61M25/00A61M29/02A61B5/02
    • A61B5/0538A61B5/0535A61M25/104A61M25/005
    • An improved dilation catheter for use in the conduct of transluminal angioplasty techniques whereby measurements may be taken to determine patency during the course of the procedure. The catheter comprises an elongated tubular member having an inelastic expander member proximate its distal end. The expander is adapted to be inflated and deflated through the introduction of a suitable fluid into the lumen of the tubular member. Disposed on either side of the expander member are sets of electrodes, preferably ring electrodes. Associated with each such electrode is a conductor which runs the length of the catheter from an associated ring electrode to the proximal end of the catheter where such conductors are connected to circuitry for performing impedance plethysmography. Thus, as the improved catheter is routed through the vascular system, the cross-sectional size of the blood vessel at plural points proximate the distal end of the catheter can be assessed, both for locating stenotic lesions to be treated and for later determining the efficacy of the treatment process.
    • 用于进行经腔血管成形术技术的改进的扩张导管,其中可以采取测量以在手术过程中确定通畅。 导管包括细长管状构件,其具有靠近其远端的非弹性膨胀器构件。 膨胀机适于通过将合适的流体引入管状构件的内腔而膨胀和放气。 在扩展器构件的任一侧上设置有电极组,优选环形电极。 与每个这样的电极相关联的是将导管的长度从相关联的电极延伸到导管的近端的导体,其中这样的导体连接到用于进行阻抗体积描记术的电路。 因此,随着改进的导管穿过血管系统,可以评估靠近导管远端的多个点处的血管的横截面尺寸,用于定位待治疗的狭窄病变并用于随后确定功效 的治疗过程。
    • 9. 发明授权
    • Self-calibration system for capture verification in pacing devices
    • 起搏装置捕获验证的自校准系统
    • US5855594A
    • 1999-01-05
    • US907609
    • 1997-08-08
    • Arthur L. OliveBrian D. PedersonVeerichetty A. KadhiresanDonald L. Villalta
    • Arthur L. OliveBrian D. PedersonVeerichetty A. KadhiresanDonald L. Villalta
    • A61N1/37A61N1/362A61N1/36
    • A61N1/3712
    • A cardiac pacing and sensing system includes a body implantable unit for generating tissue stimulation pulses and manipulating information based on sensed signals, and a catheter for transmitting pulses from the unit to a pacing electrode adjacent myocardial tissue. The unit incorporates circuitry for generating response values, one associated with each stimulation pulse, based on a predetermined characteristic or parameter of the signals evoked by the pulses. To evaluate the efficacy of the parameter in distinguishing capture versus non-capture, the stimulation pulses are generated according to a protocol of high energy pulses guaranteed to effect capture interspersed with low energy pulses guaranteed not to effect capture. Data, accumulated and sorted into separate "capture" and "non-capture" sets, provides respective capture and non-capture composite values. The ratio of the composite values is compared to a predetermined threshold, to generate an indication either accepting or rejecting the chosen parameter. A parameter, once accepted, can be employed in a self-test that either increments or decrements stimulation of signals to evaluate the capture threshold. Optionally, two or more designated parameters can be screened simultaneously and compared, with the most favorable ratio then being compared to the threshold.
    • 心脏起搏和感测系统包括用于产生组织刺激脉冲并基于感测到的信号来操纵信息的身体可植入单元,以及用于将脉冲从单元传输到心脏组织附近的起搏电极的导管。 该单元包括用于产生响应值的电路,基于由脉冲诱发的信号的预定特性或参数产生与每个刺激脉冲相关的响应值。 为了评估参数区分捕获与非捕获的功效,刺激脉冲是根据高能量脉冲的协议生成的,这些协议保证能够有效捕获散布在不能捕获的低能量脉冲上的捕获。 数据,累积并分类为单独的“捕获”和“非捕获”集合,提供相应的捕获和非捕获复合值。 将复合值的比率与预定阈值进行比较,以产生接受或拒绝所选参数的指示。 一旦被接受,一个参数就可以用于自我测试中,该测试会增加或减少信号的刺激以评估捕获阈值。 可选地,可以同时筛选两个或更多个指定参数,并以最有利的比例进行比较,然后与阈值进行比较。
    • 10. 发明授权
    • Variable rate cardiac pacer
    • 可变率心脏起搏器
    • US5036849A
    • 1991-08-06
    • US503991
    • 1990-04-04
    • John A. HauckBrian D. Pederson
    • John A. HauckBrian D. Pederson
    • A61N1/365A61N1/372A61N1/375
    • A61N1/36521
    • An endocardial lead having first and second spaced apart electrodes resides in a patient's heart. The first electrode is a sensing electrode and the second electrode is a carrier signal driving electrode. The lead has a conductor coupling a source of alternating current carrier signals of a predetermined frequency to the second electrode. A third electrode is in electrical contact with body tissues. A cardiac pacer apparatus includes a pacer can which functions as a fourth electrode and has a plastic top wherein the third electrode is located. Said third electrode acts in cooperation with the first electrode to form a pair of sensing electrodes. The sensing electrode pair is further coupled to a sense amplifier for receiving an amplifying modulated electrical signals developed across the sensing electrode pair. A demodulator and filters circuit for demodulating the modulated carrier signal and recovering the modulating signal therefrom is connected to the output of the sense amplifier. The modulating signal is proportional to instantaneous stroke volume of the patient's heart and the demodulator and filters circuit develops a control signal therefrom called a stroke volume signal. The control signal is applied to the pulse generator so as to control the rate of stimulating pulses.